Diaceutics PLC (DXRX) — Working Capital to Net Assets Ratio
Diaceutics PLC (DXRX) has a Working Capital to Net Assets ratio of 49.1% as of June 2025. Working capital of GBX18.28 Million (current assets of GBX24.46 Million minus current liabilities of GBX6.18 Million) is measured against net assets of GBX37.24 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See financial agility of Diaceutics PLC to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Diaceutics PLC Working Capital to Net Assets (2015–2024)
This chart shows how Diaceutics PLC's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2015 to 2024. As of June 2025, the ratio stands at 49.1%, reflecting working capital of GBX18.28 Million against net assets of GBX37.24 Million GBX. See how many days can Diaceutics PLC fund operations to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Diaceutics PLC (2015–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Diaceutics PLC from 2015 to 2024, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market cap of Diaceutics PLC.
| Year | WC/NA Ratio | Working Capital (GBX) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 54.6% | GBX21.76 Million | GBX39.86 Million | GBX29.53 Million | GBX7.76 Million | ▼ -3.4 pp |
| 2023 | 58.0% | GBX23.66 Million | GBX40.79 Million | GBX28.04 Million | GBX4.38 Million | ▼ -5.8 pp |
| 2022 | 63.8% | GBX27.14 Million | GBX42.51 Million | GBX30.90 Million | GBX3.75 Million | ▼ -3.6 pp |
| 2021 | 67.5% | GBX27.43 Million | GBX40.65 Million | GBX30.06 Million | GBX2.63 Million | ▼ -8.8 pp |
| 2020 | 76.3% | GBX30.70 Million | GBX40.24 Million | GBX33.62 Million | GBX2.92 Million | ▼ -4.1 pp |
| 2019 | 80.4% | GBX16.18 Million | GBX20.13 Million | GBX18.42 Million | GBX2.24 Million | ▼ -15.8 pp |
| 2018 | 96.2% | GBX2.53 Million | GBX2.63 Million | GBX6.46 Million | GBX3.93 Million | ▼ -51.1 pp |
| 2017 | 147.2% | GBX2.76 Million | GBX1.88 Million | GBX4.83 Million | GBX2.06 Million | ▼ -31.5 pp |
| 2016 | 178.7% | GBX1.81 Million | GBX1.01 Million | GBX3.23 Million | GBX1.42 Million | ▼ -59.1 pp |
| 2015 | 237.8% | GBX396.50K | GBX166.71K | GBX1.32 Million | GBX927.33K | — |